Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

PJ Online | News: Risks and benefits of antidepressants should be aired more fully with patients

Home > PJ > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7185 p197-203
16 February 2002

This article
Reprint
Photocopy


News summary

Related websites
Which? Online (www.which.net)


Risks and benefits of antidepressants should be aired more fully with patients

Patients and prescribers should be given more information about the risks and benefits of antidepressants because, if they were given more facts, more people would consider alternatives, the author of a Health Which? report believes (February 2002, p22).

The report states that several clinicians have voiced concerns about the effectiveness of antidepressants and about their unwanted effects being underplayed. Dr Joanna Moncrieff, department of psychiatry and behavioural sciences, University College London, is quoted as saying: "On the basis of evidence far less solid than generally portrayed, more and more people are being put on these medicines."

The report also suggests that the margin of improvement seen in patients treated with antidepressants is often small compared with those given placebo, and that drug companies pick and choose the trial results they want published.

David Taylor, chief pharmacist, Maudsley Hospital, London, addressed two issues raised by the report. He told The Journal that the authors argue that withdrawal symptoms related to SSRI antidepressants could be termed symptoms of dependence.

However, Mr Taylor said: "At no stage do patients crave the medication once it has been discontinued. It is not like stopping smoking, they simply feel ill." He added that no one would argue that patients who suffer tachycardia after stopping beta-blockers were addicted to beta-blockers.

On the issue of efficacy, Mr Taylor said that the fact that drug companies might suppress negative data was the same for all drugs. "Depression is not unusual in this respect," he said. "I agree that people should be better informed [about side effects] and this report gives us fair warning that we should be as honest as possible with patients." He added that he would recommend that patients suffering moderate to severe depression should be prescribed an antidepressant because the benefits outweigh the risks involved.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal

Citation: The Pharmaceutical Journal URI: 20006041

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Application and Review of Pediatric Pharmacotherapy

    Application and Review of Pediatric Pharmacotherapy

    Increase your understanding of pharmacotherapy prescribed to pediatric patients with these realistic case studies.

    £33.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00Buy now
  • Dale and Appelbe's Pharmacy and Medicines Law

    Dale and Appelbe's Pharmacy and Medicines Law

    This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.

    £57.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.